FDA Adverse Event Injury Summary report: N

ASR ACETABULAR CUPS 58

MDR report key: 2971339 · Received February 21, 2013

Report

Report Number
1818910-2013-03989
Event Type
Injury
Date Received
February 21, 2013
Date of Event
February 4, 2013
Report Date
February 4, 2013
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

PATIENT WAS REVISED DUE TO PAIN, CLUNKING IN HIS HIP, ELEVATED METAL ION LEVELS, OSTEOLYSIS, SALES REP NOTED THAT THE CUP APPEARED TO HAVE MOVED FROM THE ORIGINAL POSITION BUT IT WAS NOT LOOSE AT THE TIME OF REVISION. UPDATE LITIGATION ALLEGED THE ASR HIP WAS EXPLANTED DUE TO PAIN, GRINDING, CLICKING, POPPING, DIFFICULTY WALKING, INFECTION, DISABILITY, DISFIGUREMENT AND ELEVATED BLOOD LEVELS OF CHROMIUM AND COBALT.

Description of Event or Problem · 1

PATIENT WAS REVISED DUE TO PAIN, CLUNKING IN HIS HIP, ELEVATED METAL ION LEVELS, OSTEOLYSIS, SALES REP NOTED THAT THE CUP APPEARED TO HAVE MOVED FROM THE ORIGINAL POSITION BUT IT WAS NOT LOOSE AT THE TIME OF REVISION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
76410 ASR ACETABULAR CUPS 58 ACETABULAR CUP KWA DEPUY INTERNATIONAL 2112731

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention